Picture of BioArctic AB logo

BIOA B BioArctic AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapHigh Flyer

Brief: NHS Says Awaiting Final Decision From NICE To Determine If Lecanemab Should Be Offered By NHS In England

Aug 22 (Reuters) - 
    NHS: 
  
    * NHS-AWAITS FINAL DECISION FROM NICE FOR CLINICAL BENEFITS,
COST-EFFECTIVENESS OF LECANEMAB TO DETERMINE IF IT SHOULD BE
OFFERED BY NHS IN ENGLAND


 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on BioArctic AB

See all news